Abstract
We report a successful treatment with rituximab in a patient with CANOMAD neuropathy resistant to previous therapy. The titers of anti-disialosyl antibodies were decreased 3 months after the beginning of the treatment and the sensory ataxia clearly improved after 9 months of therapy.
This is a preview of subscription content, log in via an institution to check access.
References
Attarian S, Boucraut J, Hubert AM, Uzenot D, Delmont E, Verschueren A, Franques J, Azulay JP, Pouget J (2009) Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp.2009.185736
Delmont E, Benaïm C, Launay M, Sacconi S, Soriani MH, Desnuelle C (2009) Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? J Neurol 256(11):1876–1880
Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572–2581
Graham RC, Hughes RA (2006) A modified peripheral neuropathy scale: the overall neuropathy limitations scale. J Neurol Neurosurg Psychiatry 77:973–976
Merkies IS, Schmitz PI, van de Meche FG, van Doorn PA (2002) Psychometric evaluation of new sensory scale in immune mediated polyneuropathies. Neurology 54:943–949
Siddiqui K, Cahalane E, Keogan M, Hardiman O (2003) Chronic ataxic neuropathy with cold agglutinins: atypical phenotype and response to anti-CD20 antibodies. Neurology 61:1307–1308
Stübgen JP (2008) B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders. J Neuroimmunol 204:1–12
Willisson HJ, O’Hanlon GM (1999) The immunopathogenesis of Miller-Fisher syndrome. J Neuroimmunol 100:3–12
Willison HJ, O’Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, Fuhr P, Ford H, Hahn A, Renaud S, Katifi HA, Ponsford S, Reuber M, Steck A, Sutton I, Schady W, Thomas PK, Thompson AJ, Vallat JM, Winer J (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124:1968–1977
Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591–2625
Yelnik A, Bonan I (2008) Clinical tools for assessing balance disorders. Neurophysiol Clin 38:439–445
Acknowledgments
Ethics committee of CHU de Nice approval was obtained and the patient gave informed consent.
Conflict of interest statement
Authors report no financial disclosure.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delmont, E., Jeandel, P.Y., Hubert, A.M. et al. Successful treatment with rituximab of one patient with CANOMAD neuropathy. J Neurol 257, 655–657 (2010). https://doi.org/10.1007/s00415-009-5412-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5412-z